Ubrelvy (ubrogepant) is an oral medication indicated for the acute treatment of migraine attacks with or without aura in adults. It belongs to the class of calcitonin gene-related peptide (CGRP) receptor antagonists, which work by blocking the activity of CGRP, a protein involved in migraine attacks. Ubrelvy is not intended for the preventive treatment of migraines. . Please Note that product description, color, ingredients, package and other information maybe different from the original pack kindly check the product for more accurate details.
